Navigation Links
Circulating tumor cells can provide 'real-time' information on patient's current disease state
Date:9/28/2010

DENVER Circulating tumor cells (CTCs) may be a promising alternative, noninvasive source of tumor materials for biomarker assessment, according to data presented at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development.

"The basic idea is that CTCs can provide real-time information about a patient's current disease state, acting as a 'liquid biopsy,'" said Siminder Kaur Atwal, Ph.D., senior research associate at Genentech. "They are much less invasive than tumor biopsies because they can be detected from a blood draw and don't require surgical intervention."

For this study, Atwal and colleagues compared the CTC capture efficiency of the Food and Drug Administration-approved CellSearch platform with two biochip platforms, using tumor cell lines spiked into whole blood. They tried to detect epidermal growth factor receptor (EGFR) protein expression in CTCs from patients with lung cancer and HER2 expression or amplification in CTCs in patients with metastatic breast cancer.

Under the tested conditions, CellSearch and the newer biochip platforms offered similar efficiency. Further, capture efficiency was dependent on EpCAM (epithelial cell adhesion molecule) expression.

"This may be a limitation in capturing CTCs from certain tumor types, notably triple-negative breast cancers," Atwal said.

Captured CTCs were amenable to biomarker analyses such as HER2 status, qRT-PCR for breast cancer subtype markers, KRAS mutation detection and EGFR staining by immunofluorescence, the researchers found. In patients with HER2-positive breast cancer, HER2 status in CTCs and tumor tissue generally correlated; however, in one patient subset, HER2 status changed from the primary tumor at diagnosis. This finding indicates that in some cases, CTCs may offer a real-time view of a patient's biomarker status that is different from diagnostic tissue, Atwal said.

Some improvements are necessary in CTC detection and capture before the technology can be generally useful in clinical biomarker analysis, Atwal said. Future studies will focus on evaluating different detection and capture methods with a particular emphasis on tumor types with a low EpCAM expression. In addition, future research will look for other biomarkers in CTCs to determine if they represent a patient's tumor, she said.


'/>"/>

Contact: Jeremy Moore
jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Related medicine news :

1. Revisiting the need to detect circulating tumor cells
2. Improved device provides more rapid, comprehensive analysis of circulating tumor cells
3. Survival in metastatic breast cancer directly linked to circulating tumor cells
4. Circulating tumor cells correlate with poorer survival in pancreatic cancer patients
5. Researchers discover new way to kill pediatric brain tumors
6. Researchers create drug to keep tumor growth switched off
7. Fluorescent probes light up cancerous tumors
8. Scripps Health Begins Pioneering Study of Human Tumor Sequencing in Cancer Patients
9. Drug for advanced kidney cancer shrinks tumors prior to surgery
10. Researchers discover second protective role for tumor-suppressor
11. Personalizing cancer: Creating biomarkers from tumor DNA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 24, 2017 , ... ... of a new report from the Frank Hawkins Kenan Institute of Private ... business leaders, academics and policy makers identified concrete solutions at the “What’s Next, ...
(Date:1/24/2017)... ... January 24, 2017 , ... The results from the ... and particularly good news for prostate cancer patients: incidents of cancer is down as ... the report the cancer death rate has dropped from its peak of 215.1 in ...
(Date:1/24/2017)... ... January 24, 2017 , ... American Family Care (AFC) has opened a new ... care for residents in the area. The Bedford clinic will be the nineteenth location ... years by Dave Adams and Dr. Kristina Orio. Adams and Orio also independently own ...
(Date:1/24/2017)... Overland Park, KS (PRWEB) , ... January 24, ... ... rating to Premensa, a leading natural supplement for relieving premenstrual syndrome, or ... premenstrual syndrome at some point. These symptoms can include cramps, constipation, irritability, headaches, ...
(Date:1/24/2017)... ... 2017 , ... “Who Would Have Dreamed: A Novel of Miracles”: a beautiful and poignant ... understand its purpose in her life. “Who Would Have Dreamed: A Novel of Miracles” is ... love of writing. , Sharon shares that she started her spiritual journey later ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... Market Research Future has a half cooked research report on Global Wound ... and expected to continue its growth by the end of 2022. ... Wound Closure ... 2019 and reaching a value of 13 billion by 2019 and 21 ... Wound Closure Device Market has been growing rapidly and is expected to ...
(Date:1/24/2017)... , Jan. 24, 2017 Market Research Future has a ... Market. The global market for Plastic Surgery & Integumentary System is ... end of the forecasted period. Market Highlights ... Global Plastic Surgery & Integumentary ... predicted that the market will reach high growth figures and thriving ...
(Date:1/24/2017)... 2017 Research and Markets has announced the ... - Product, Material - Forecast to 2025" report to their ... The ... CAGR of around 5.4% over the next decade to reach approximately ... that the market is witnessing include 3D medical printing is expected ...
Breaking Medicine Technology: